Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Japan approves Keytruda plus Lenvima combination for endometrial cancer treatment
Keytruda plus Lenvima therapy is indicated to treat endometrial carcinoma. Credit: 2009-2021 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.
Keytruda plus Lenvima therapy is indicated to treat endometrial carcinoma. Credit: 2009-2021 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.